Literature DB >> 34515242

Bronchiectasis and Nontuberculous Mycobacteria: It Is Not Over till It Is Over.

Hyung-Jun Kim1, Jae-Joon Yim2,3.   

Abstract

Entities:  

Mesh:

Year:  2021        PMID: 34515242      PMCID: PMC8743898          DOI: 10.1159/000518329

Source DB:  PubMed          Journal:  Respiration        ISSN: 0025-7931            Impact factor:   3.580


× No keyword cloud information.
  12 in total

1.  Quantifying heterogeneity in a meta-analysis.

Authors:  Julian P T Higgins; Simon G Thompson
Journal:  Stat Med       Date:  2002-06-15       Impact factor: 2.373

Review 2.  An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases.

Authors:  David E Griffith; Timothy Aksamit; Barbara A Brown-Elliott; Antonino Catanzaro; Charles Daley; Fred Gordin; Steven M Holland; Robert Horsburgh; Gwen Huitt; Michael F Iademarco; Michael Iseman; Kenneth Olivier; Stephen Ruoss; C Fordham von Reyn; Richard J Wallace; Kevin Winthrop
Journal:  Am J Respir Crit Care Med       Date:  2007-02-15       Impact factor: 21.405

3.  Research priorities in bronchiectasis: a consensus statement from the EMBARC Clinical Research Collaboration.

Authors:  Stefano Aliberti; Sarah Masefield; Eva Polverino; Anthony De Soyza; Michael R Loebinger; Rosario Menendez; Felix C Ringshausen; Montserrat Vendrell; Pippa Powell; James D Chalmers
Journal:  Eur Respir J       Date:  2016-06-10       Impact factor: 16.671

Review 4.  British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD).

Authors:  Charles S Haworth; John Banks; Toby Capstick; Andrew J Fisher; Thomas Gorsuch; Ian F Laurenson; Andrew Leitch; Michael R Loebinger; Heather J Milburn; Mark Nightingale; Peter Ormerod; Delane Shingadia; David Smith; Nuala Whitehead; Robert Wilson; R Andres Floto
Journal:  Thorax       Date:  2017-11       Impact factor: 9.139

5.  Clarithromycin therapy for bacteremic Mycobacterium avium complex disease. A randomized, double-blind, dose-ranging study in patients with AIDS. AIDS Clinical Trials Group Protocol 157 Study Team.

Authors:  R E Chaisson; C A Benson; M P Dube; L B Heifets; J A Korvick; S Elkin; T Smith; J C Craft; F R Sattler
Journal:  Ann Intern Med       Date:  1994-12-15       Impact factor: 25.391

6.  Non-tuberculous mycobacterial disease is common in patients with non-cystic fibrosis bronchiectasis.

Authors:  Mehdi Mirsaeidi; Walid Hadid; Basel Ericsoussi; Daniel Rodgers; Ruxana T Sadikot
Journal:  Int J Infect Dis       Date:  2013-05-16       Impact factor: 3.623

7.  British Thoracic Society Guideline for bronchiectasis in adults.

Authors:  Adam T Hill; Anita L Sullivan; James D Chalmers; Anthony De Soyza; Stuart J Elborn; Andres R Floto; Lizzie Grillo; Kevin Gruffydd-Jones; Alex Harvey; Charles S Haworth; Edwin Hiscocks; John R Hurst; Christopher Johnson; Peter W Kelleher; Pallavi Bedi; Karen Payne; Hashem Saleh; Nicholas J Screaton; Maeve Smith; Michael Tunney; Deborah Whitters; Robert Wilson; Michael R Loebinger
Journal:  Thorax       Date:  2019-01       Impact factor: 9.139

8.  Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline.

Authors:  Charles L Daley; Jonathan M Iaccarino; Christoph Lange; Emmanuelle Cambau; Richard J Wallace; Claire Andrejak; Erik C Böttger; Jan Brozek; David E Griffith; Lorenzo Guglielmetti; Gwen A Huitt; Shandra L Knight; Philip Leitman; Theodore K Marras; Kenneth N Olivier; Miguel Santin; Jason E Stout; Enrico Tortoli; Jakko van Ingen; Dirk Wagner; Kevin L Winthrop
Journal:  Clin Infect Dis       Date:  2020-08-14       Impact factor: 9.079

9.  Pulmonary nontuberculous mycobacterial disease, Ontario, Canada, 1998-2010.

Authors:  Theodore K Marras; David Mendelson; Alex Marchand-Austin; Kevin May; Frances B Jamieson
Journal:  Emerg Infect Dis       Date:  2013-11       Impact factor: 6.883

10.  New-onset nontuberculous mycobacterial pulmonary disease in bronchiectasis: tracking the clinical and radiographic changes.

Authors:  Nakwon Kwak; Jong Hyuk Lee; Hyung-Jun Kim; Sung A Kim; Jae-Joon Yim
Journal:  BMC Pulm Med       Date:  2020-11-10       Impact factor: 3.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.